Loading
Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot
Abstract Population genomic screening enables the identification of individuals at high risk of medically actionable conditions before disease onset, yet real-world feasibility studies are lacking. In …
Access to care affects electronic health record reliability and AI-driven disease prediction
Abstract Despite well-documented healthcare access disparities, their impact on electronic health record reliability and resulting clinical prediction models remains poorly understood. Here, analysing …
An open-source platform for multimodal digital trace data collection from smartphones
Abstract Smartphone-based digital trace data can offer powerful insights for identifying behavioural patterns and health risks. However, existing tools for comprehensive data collection lack scalabili …
Large-scale screening of blinding eye diseases from routine blood tests
Abstract Blinding eye diseases pose a substantial global health burden, yet current screening strategies are limited by resource demands and poor accessibility, particularly in underserved settings. L …
Public use of a generalist LLM chatbot for health queries
Abstract Here we analyse over 500,000 de-identified health-related conversations with Microsoft Copilot from January 2026 to characterize what people ask conversational artificial intelligence (AI) ab …
Remote monitoring of heart failure exacerbations using a smartwatch
Abstract Heart failure (HF) involves cycles of remission and exacerbation, which are poorly characterized by static disease measures. Consumer wearables have an understudied potential for daily monito …
Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial
Abstract Adjunctive corticosteroids such as dexamethasone are recommended in tuberculous meningitis treatment, despite modest and heterogeneous survival benefit. Leukotriene A4 hydrolase (LTA4H) genot …
Single-cell atlas of the developing Down syndrome brain cortex
Abstract Down syndrome (DS), caused by trisomy of chromosome 21, is the leading genetic cause of intellectual disability, yet the mechanisms disrupting fetal brain development remain unclear. We perfo …
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Abstract Heterozygous familial hypercholesterolemia is a common genetic disorder characterized by lifelong elevation of serum low-density lipoprotein cholesterol (LDL-C) and premature atherosclerotic …
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial
Abstract Cancer interception is a preventative approach aiming to reduce cancer incidence by targeting precancers and early-stage cancers. Lynch syndrome (LS) is a prevalent hereditary cancer syndrome …
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
Abstract Tumor-infiltrating T cells have been the primary focus of cancer immunotherapy; however, accumulating evidence points to a critical role for B cells and plasma cells in shaping responses to i …
An LLM chatbot to facilitate primary-to-specialist care transitions: a randomized controlled trial
Abstract Patient-facing large language models (LLMs) hold potential to streamline inefficient transitions from primary to specialist care. We developed the preassessment (PreA), an LLM chatbot co-desi …
An international mega-analysis of psychedelic drug effects on brain circuit function
Abstract Psychedelic drugs are re-emerging as promising scientific and clinical tools. However, despite a rapidly expanding literature on their therapeutic value, the neural mechanisms underlying psyc …
Deleterious coding variation associated with autism is shared across ancestries
Abstract The past decade has seen remarkable progress in identifying genes that, when impacted by deleterious coding variation, confer high likelihood for autism spectrum disorder (ASD), intellectual …
Citywide premarital genomic screening in a Middle Eastern population
Abstract Here we describe the feasibility and first implementation of a mandatory, citywide premarital genomic screening program comprising the sequencing of 782 genes, implicated in autosomal recessi …
An atlas of exposome–phenome associations in health and disease risk
Abstract Nongenetic exposures comprising the ‘exposome’, including diet, lifestyle, infections and pollutants, shape many clinical phenotypes yet the evidence remains fragmented. Here we conducted an …
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
Abstract LRRK2 (encoding leucine-rich repeat kinase 2) variants are the most common genetic cause of Parkinson’s disease (PD). Lowering LRRK2 levels and/or inhibiting LRRK2 activity may modify PD-asso …
Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy
Abstract KCNT1-related epileptic encephalopathy, including epilepsy of infancy with migrating focal seizures, is a severe neurodevelopmental disorder associated with refractory seizures, profound neur …
AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial
Abstract Artificial intelligence (AI) systems have been demonstrated to improve the accuracy of screening mammograms. Here this prospective, paired, noninferiority clinical trial evaluated whether AI …
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma
Abstract Cancer generally takes years to evolve, and early diagnosis can prevent life-threatening cancer. Establishing a link between precancerous states and cancer is essential for effective screenin …
Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes
Abstract Individuals of African ancestry carrying APOL1 (apolipoprotein L1) high-risk genotypes face a markedly increased risk of kidney failure, yet tools to identify those individuals likely to prog …
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis
Abstract Elevated blood levels of phosphorylated tau (p-tau) are diagnostic of Alzheimer disease and are associated with the deposition of amyloid-β in the cerebral neuropil. Elevated p-tau levels hav …
Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studies
Abstract Background Next-generation sequencing (NGS) tests are integral to oncology care. To address the need for clinical and NGS data management, interpretation, and reporting, we developed iCatalog …
An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features
Abstract Background Medulloblastoma (MB), the most common malignant pediatric brain tumor, lacks prognostic tools integrating clinical, molecular, and treatment-related characteristics for individuali …
Antigen heterogeneity in the development and clinical validation of a multiplexed urine test for tuberculosis
Abstract Background Tuberculosis (TB) is one of the leading causes of death worldwide, even though it is curable using antibiotics. Most people who die of TB never begin treatment because diagnostics …
Best cochlear locations for delivering interaural timing cues in electric hearing
Abstract Background An increasing number of children and adults who are deaf are receiving cochlear implants in both ears (bilateral CIs or BiCIs), promoting the possibility of access to binaural cues …
Reconstructing the pharmacogenomic landscape of psychiatric medication metabolism in the Indian population
Abstract Background With the advent of genomic technologies, pharmacogenomics has evolved significantly. Such advancement facilitates comprehensive identification of common and rare alleles crucial fo …
High-throughput spheroid-based assay for functional breast cancer precision medicine facilitated by deep learning
Abstract Background Despite rapid advances in treatment, breast cancer remains the leading cause of cancer mortality in women, with triple negative breast cancers having a particularly poor prognosis. …
Nalmefene and naltrexone reduce alcohol intake via selective efficacy in subpopulations distinguished by behavioral and blood-based biomarkers
Nalmefene and naltrexone are two drug treatments for alcohol use disorder, but disagreement exists on which is more effective. Despite ongoing controversy, treatment outcomes have only been compared a …